Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma-Reference-Cited by-同舟云学术

Single‐cell profiling‐guided combination therapy of c‐Fos and histone deacetylase inhibitors in diffuse large B‐cell lymphoma

Published:2022-05 Issue:5 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Wang Luqiao¹²³,Wu Zijuan¹²³^ORCID,Xia Yi¹²³,Lu Xueying¹²³,Li Ji⁴,Fan Lei¹²³,Qiao Chun¹²³,Qiu Hairong¹²³,Gu Danling¹²³,Xu Wei¹²³,Li Jianyong¹²³⁵,Jin Hui¹²³

Affiliation:

1. Department of Hematology, Pukou CLL Center, the First Affiliated Hospital of Nanjing Medical University Jiangsu Province Hospital Nanjing China

2. Key Laboratory of Hematology of Nanjing Medical University Nanjing Medical University Nanjing China

3. Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine Nanjing Medical University Nanjing China

4. Singleron Biotechnologies Nanjing China

5. National Clinical Research Center for Hematologic Diseases the First Affiliated Hospital of Soochow University Suzhou China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.798

Reference44 articles.